DSG2 and esophageal squamous cell carcinoma: To evaluate the level of DSG2 in serum samples, 459 participants were selected, including 97 patients with ESCC and 92 healthy volunteers in the training cohort; 54 patients with ESCC and 59 healthy volunteers in the validation cohort; and 96 patients with EJA and 61 healthy volunteers (Figure 1).